8-K: Therapeutic Solutions International Announces Loyalty Dividend of Campbell Neurosciences Shares

Therapeutic Solutions International (TSOI) is offering a loyalty dividend of Campbell Neurosciences (CNSI) shares to its shareholders, after withdrawing a previous attempt due to staleness.

Summary

• Therapeutic Solutions International (TSOI) has announced a loyalty dividend of shares in its partially owned subsidiary, Campbell Neurosciences, Inc. (CNSI).
• The company had previously filed for a similar dividend distribution on March 27, 2023, but withdrew it on March 12, 2024, due to staleness.
• A new corporate action was filed with FINRA on May 3, 2024, to distribute up to 10 million CNSI shares as a loyalty dividend to TSOI shareholders.
• The dividend will be distributed at a ratio of 0.0022 CNSI shares for each TSOI share owned, based on shareholdings as of April 30, 2024.
• The record date for the dividend is May 15, 2024, and the offer will remain open for 90 days, until approximately August 14, 2024.
• Shareholders will receive details on how to accept the dividend from their broker/dealer or the Distribution Agent.
• A Shareholders Rights Agreement may be included with the dividend distribution.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there was a delay, the company is moving forward with the dividend distribution, which is a positive for shareholders. However, the complexity of the process and the need for shareholders to elect to participate may cause some concern.

Positives

• The loyalty dividend provides a potential benefit to TSOI shareholders.
• The company is actively working to distribute the CNSI shares after a previous attempt failed.
• The dividend is being offered with the consent of a majority of eligible voting shares.

Negatives

• The initial dividend distribution attempt was withdrawn due to staleness, indicating a potential issue with the initial process.
• Shareholders must actively elect to accept the dividend, which may cause some to miss out.

Risks

• The distribution process may encounter unforeseen issues or delays.
• The value of CNSI shares may fluctuate, impacting the value of the dividend.
• Shareholders may not fully understand the terms of the dividend offer or the Shareholders Rights Agreement.

Future Outlook

The company intends to complete the distribution of CNSI shares to eligible TSOI shareholders within the 90-day offer period.

Management Comments

• The company deemed it in the best interest of the Company and TSOI Shareholders to refile the corporate action.
• The officers of the Company are authorized to carry out the purposes of the Company and its corporate action.

Industry Context

This announcement is specific to TSOI and its shareholders, and does not directly relate to broader industry trends, but it does show a method of rewarding shareholders.

Comparison to Industry Standards

• While not directly comparable to standard dividend practices of large cap companies, this type of loyalty dividend is not uncommon for smaller companies looking to reward shareholders.
• The use of a subsidiary's shares as a dividend is a less common approach than cash dividends, but it can be a way to distribute value without impacting the company's cash reserves.
• The 90 day offer period is a standard practice for corporate actions of this type.

Stakeholder Impact

• Shareholders will receive a loyalty dividend in the form of CNSI shares.
• The company's management is taking steps to reward shareholders.
• Brokers and the Distribution Agent will be involved in the distribution process.

Next Steps

• The company will mail correspondence to shareholders of record with details on how to accept the dividend.
• The company will distribute the CNSI shares to shareholders who elect to accept the offer.
• The company will provide a Shareholders Rights Agreement with the dividend distribution.

Key Dates

Keywords

dividend, loyalty dividend, share distribution, Campbell Neurosciences, CNSI, Therapeutic Solutions International, TSOI, corporate action